Delivery Order SPE2DB24D2106-SPE2DB24FAUKF
Award Date
6/24/24
Potential Completion Date
6/25/24
Potential Value
$7.3K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $7,640.32 contract is for the supply of STELARA 90 MG/ML SYRINGE to support the medical needs of the Department of Defense. This order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC covers a broad range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of the drug Stelara 90 mg/ml syringe. The award, valued at $7,108.82, has a period of performance through May 10, 2024. This delivery order is placed under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group worth up to $499,999,999, which allows the DLA to issue firm fixed-price orders for a wide...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,461.12 award is for the supply of 130 mg/26 ml vials of the drug Stelara, with a period of performance through December 6, 2024. This order is issued under a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which allows the agency to place delivery orders for a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,461.12, is for the supply of 4565440977 - STELARA 130 MG/26 ML VIAL 26ML to support the recurring medical supply needs of military health facilities.
The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,930.42 firm fixed-price contract is for the provision of STELARA 90 MG/ML SYRINGE, a specialized biologic medication.
The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its small business status to secure this direct award from the DLA. This...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $3,730.56 order is for 130 mg/26 mL vials of the drug STELARA, with a performance period ending on April 5, 2024.
The order was placed under DMS Pharmaceutical Group's $4,999,999 indefinite delivery, indefinite quantity (IDIQ) contract SPE2DB22D9143 with DLA, which allows the agency to issue delivery orders for a broad range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The $3,730.56 contract is for the delivery of STELARA 130 MG/26 ML VIAL 26ML, a biologic pharmaceutical product, with a completion date of April 18, 2024. This award is part of a larger $4,999,999 indefinite delivery vehicle (IDV) contract SPE2DB between DMS Pharmaceutical Group and DLA, which enables DLA to issue delivery orders...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,730.56, is for the delivery of STELARA 130 MG/26 ML VIAL 26ML, a specialty pharmaceutical product.
The contract is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,499.08 contract is for the delivery of Stelara 45 mg/0.5 ml syringe 0.5 ml, a specialty biologic drug, to fulfill the recurring pharmaceutical supply needs of military health facilities. The order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $8,059.74 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML syringes. The award is not associated with any set-aside designation.
The contract is part of DMS Pharmaceutical Group's broader Indefinite Delivery Contract (IDC) with the DLA, valued at up to $499,999,999, which allows the agency to issue...